Home Business Merck Deal for Seagen Seen as Unlikely by Earnings Release

Merck Deal for Seagen Seen as Unlikely by Earnings Release

by News
20 views
merck-deal-for-seagen-seen-as-unlikely-by-earnings-release

Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized ahead of the pharmaceutical giant’s earnings later this month, though the talks remain on track, according to people familiar with the matter.

The Wall Street Journal reported earlier this month that Merck aimed to agree on a purchase of the cancer biotech within a few weeks, a plan that has since been delayed, the people said.

You may also like

Leave a Reply